Abstract
Positron emission tomography (PET) using [F-18]2-fluoro-2-deoxyglucose (FDG) fused with CT (18F-FDG PET/CT) has been widely adopted in oncological imaging. However, it is known that benign lesions and other metabolically active tissues, such as brown adipose tissue (BAT), can accumulate 18F-FDG, potentially resulting in false-positive interpretation. Previous studies have reported that 18F-FDG uptake in BAT is more common in children than in adults. We illustrate BAT FDG uptake in various anatomical locations in children and adolescents. We also review what is known about the effects of patient-related physical attributes and environmental temperatures on BAT FDG uptake, and discuss methods used to reduce BAT FDG uptake on 18F-FDG PET.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Positron emission tomography (PET) using [F-18]2-fluoro-2-deoxyglucose (FDG) fused with CT (18F-FDG PET/CT) has been widely adopted as a primary imaging modality in the evaluation of cancer patients [1–5]. However, a number of pitfalls are encountered in 18F-FDG PET interpretation. For example, uptake in benign lesions and other metabolically active tissues, such as brown adipose tissue (BAT), can lead to false-positive interpretation and inaccurate disease staging [6–11]. Previous studies have reported that BAT FDG uptake is more common in children than in adults. The purpose of this article is to review: (1) prevalence, anatomical distribution and appearance of metabolically active BAT in children and adolescents; (2) effects of patient-related physical attributes (i.e. age, gender, body mass index) and environmental temperatures (i.e. outdoor ambient temperature, indoor room temperature) on BAT FDG uptake, and (3) strategies currently used to prevent BAT FDG uptake in 18F-FDG PET.
Brown adipose tissue
Brown adipose tissue differs from white adipose tissue in histological appearance, function and anatomical distribution. BAT contains granular cytoplasm with multiple fat vacuoles within each adipocyte and is characterized by a high degree of vascularity and mitochondrial density, which accounts for its characteristic brown color [12]. White adipose tissue serves as a site for lipid storage and insulation, whereas BAT serves as the primary site for non-shivering thermogenesis [13–15]. The presence of uncoupling protein 1 (UCP1), which is unique to BAT, enables non-shivering thermogenesis, which is particularly important during the initial decade of life [14, 16, 17]. Although the anatomical distribution of metabolically active BAT is relatively widespread in children, BAT regresses and becomes predictably concentrated in certain anatomical locations with increasing age [12, 15].
Anatomical distribution of BAT FDG Uptake
18F-FDG uptake in BAT is driven by sympathetic release of norepinephrine, resulting in activation of β3 receptors [13]. Subsequent 18F-FDG uptake through glucose transporter 1 (GLUT 1) and glucose transporter 4 (GLUT 4) [18, 19] is usually bilateral and symmetrical, although focal and asymmetrical uptake is not uncommon in some anatomical regions. BAT FDG uptake in children is most commonly seen in the neck and supraclavicular-axillary, mediastinal, paravertebral-intercostal, mediastinal, perinephric-suprarenal and upper abdominal wall regions (Fig. 1), more in some regions than others. Whenever possible 18F-FDG PET images should be correlated with co-registered CT to improve anatomical localization and exclude underlying soft-tissue abnormality [10, 20].
Neck
Okuyama et al. [21] were the first to provide convincing evidence of BAT in the neck in their study of 123I-metaiodobenzylguanidine distribution in children with neuroendocrine tumors. The classic distribution of BAT FDG uptake in the neck is bilateral and symmetrical and represents a series of discrete foci of BAT arranged in a curvilinear pattern [13] (Figs. 2 and 3). Often, BAT FDG uptake in the neck is seen in the posterior cervical region. In some patients, two foci of suboccipital uptake are seen on each side of the neck. In patients with prior intervention such as surgery or radiation affecting the neck or cervical sympathetic chain, uptake might be focal and asymmetrical (Fig. 4). Brown adipose tissue FDG uptake in the neck can obscure small pathological lesions. Furthermore, misregistration of PET and CT can complicate differentiation of uptake in neck nodes from BAT.
Supraclavicular-axillary region
In pediatric 18F-FDG PET, BAT FDG uptake is most commonly found in the supraclavicular-axillary region [9]. FDG uptake in this area typically appears symmetrical and fusiform, extending contiguously from the inferior neck to the axillae (Figs. 2 and 3). As in the neck, uptake in the supraclavicular-axillary region can be markedly intense and can obscure small pathological lesions. During the era of 18F-FDG PET-only imaging, fusiform uptake in the neck and supraclavicular regions had been attributed to muscle activity rather than BAT because physiological uptake in this region resolved after administration of benzodiazepine, a muscle relaxant and anxiolytic [22]. However, improved anatomical localization with the introduction of 18F-FDG PET/CT has revealed that 18F-FDG uptake in this area is in fact often attributable to BAT FDG uptake [9, 11].
Paravertebral-intercostal region
BAT FDG uptake in this region presents as bilateral, symmetrical foci in the intercostal spaces along the costovertebral junctions (Figs. 2, 5 and 6) [11, 23]. In cases with a high degree of BAT FDG uptake in this region, uptake is readily identifiable using coronal images. Special attention should be focused on differentiating BAT FDG uptake in this region from skeletal or paraspinal lesions.
Mediastinum
BAT FDG uptake in the mediastinum is often seen in the paratracheal, paraesophageal and perivascular regions (Figs. 2, 3 and 6) and might also be evident in the pericardial region. Most often, BAT FDG uptake is seen between and surrounding intrathoracic blood vessels such as the azygos and hemiazygos veins (Fig. 2), great vessels in the upper mediastinum (Fig. 2), and aorta (Fig. 6). Typically, BAT FDG uptake in the mediastinum appears as relatively symmetrical, rounded foci of activity (Fig. 2). However, unlike the neck, asymmetrical uptake is not uncommon (Fig. 3).
Mediastinal BAT uptake is almost always seen in conjunction with BAT FDG uptake in the neck and/or supraclavicular-axillary regions. However, Truong et al. [10] reported five patients with isolated mediastinal BAT FDG uptake. Focal BAT FDG uptake in the mediastinum can be easily misinterpreted as malignancy. Therefore, careful correlation of metabolic activity on 18F-FDG PET with anatomy on CT is highly recommended [10].
Perinephric-suprarenal region
BAT FDG uptake in this region presents as focal activity adjacent to the upper pole of the kidney, or curvilinear activity surrounding the lateral aspect of the kidneys (Fig. 7). Increased suprarenal BAT FDG uptake can mimic an adrenal neoplasm [8]. 18F-FDG PET/CT fusion images can be used for precise localization and to exclude abnormal adrenal mass.
Abdominal wall
Based on our experience, BAT FDG uptake in the abdominal wall presents as focal or linear activity deep to the midline linea alba, which separates the left and right rectus sheaths (Figs. 6 and 7).
Physical traits affecting BAT FDG uptake
Age
BAT FDG uptake is more common in children and adolescents than in adults [10, 11]. Truong et al. [10] reported mediastinal brown fat uptake in 1.3% of adults compared with 50% of children, and Yeung et al. [11] showed that metabolically active BAT uptake in the neck is significantly more prevalent in children (15%) than in adults (1.9%). Furthermore, Gelfand et al. [24] reported that BAT FDG uptake is seen more frequently in adolescents (>10 y) than younger children.
Gender
In adults, BAT FDG uptake is more common in women than in men [9, 11, 23, 25]. Cypess et al. [25] reported BAT FDG uptake in 7.5% of women versus 3.1% of men. Similarly, Truong et al. [10], Yeung et al. [11], and Cohade et al. [9] reported a greater prevalence of BAT FDG uptake in females. Results from rodent studies suggest that this gender difference is explained by relatively larger size and higher density of cristae within BAT mitochondria of females, resulting in greater glucose utilization and higher thermogenic capacity [26]. However, Gelfand et al. [24] observed that the prevalence of BAT FDG uptake in children did not differ between boys and girls, although there was a greater incidence of BAT FDG uptake in adolescents attributed largely to adolescent girls [24]. It would be valuable for future studies with larger pediatric populations to investigate whether there exists a gender difference when children and adolescent subgroups are considered separately.
Body mass and body mass index
In adult studies, Cypess et al. [25] and Rodriguez-Cuenca et al. [26] each reported an inverse correlation between BAT FDG uptake and body mass index (BMI). However, other studies have failed to reproduce these findings in age- and gender-matched control groups [9–11]. The effect of body mass and BMI in children has not been well-evaluated. Often, increasing body mass is accompanied by advancing age. In addition, since absolute BMI might be a less accurate predictor of body fat in children than in adults [27], future studies in children might benefit by using BMI percentile instead of absolute BMI.
Effect of environmental temperature on BAT FDG uptake
Outdoor temperature
Cold-induced thermogenesis in BAT is driven by sympathetic release of norepinephrine, resulting in activation of β receptors [13, 18, 19]. It is believed that increased glucose transporter activity during thermogenesis is responsible for increased BAT FDG uptake on PET following cold exposure [18] (Fig. 6). In a study of 1,017 patients, Cohade et al. [28] reported that the prevalence of 18F-FDG uptake in supraclavicular BAT in adults increased during the winter months (January to March) compared to the rest of the year. The prevalence of BAT FDG uptake was also higher during the winter months for the subset of children in that study, although differences did not reach statistical significance because of the relatively small pediatric sample size (n = 21) [28]. Cohade et al. [28] hypothesized that even if there is an acute response in BAT activity because of cold exposure, a prolonged period of cold exposure might be necessary to elicit increased BAT FDG uptake on PET, as evidenced by a delay of up to 2 months between cold exposure and increased BAT FDG uptake on PET [28]. However, findings from other studies do not support the necessity of prolonged cold exposure in this regard. In a study of 1,159 patients, including 22 children, Kim et al. [29] reported changes in BAT FDG uptake within days of cold exposure and found that the relationship between BAT FDG uptake and outdoor temperature was most significant when correlated with short-term averages in temperature (i.e. <7 days). Furthermore, animal studies have reported acute changes in BAT activity within minutes of changes in environmental temperature [14]. The relationship between outdoor temperature and BAT FDG uptake remains to be thoroughly investigated in children.
Indoor temperature
It has been shown that increasing indoor room temperature can significantly reduce BAT FDG uptake in children [30] (Fig. 8). Zukotynski et al. [30] reported that the incidence of BAT FDG uptake decreased from 27% to 9% after increasing the indoor temperature from 21°C to 24°C and maintaining children in the warmed environment for 30 min prior to and 1 h after intravenous tracer administration. Passively or actively warming patients prior to and after the injection of 18F-FDG might be a safe non-pharmacological approach to prevent BAT FDG uptake in children [31].
Note that indoor temperatures must also be controlled during the summer in order to minimize BAT FDG uptake. Bar-Sever et al. [32] suggested that uncomfortably cool air conditioning might have caused BAT FDG uptake despite year-round warm climates. Gelfand et al. [24] also alluded to variations in indoor temperature as a potential confounding influence in their study, which did not report a relationship between outdoor temperature and BAT FDG uptake.
Current methods to reduce BAT FDG uptake
Pharmacological approaches
As mentioned previously, heat production by BAT is stimulated by norepinephrine released from the sympathetic nervous system in response to cold temperatures [14]. β1, β2 and predominantly β3 receptors are expressed in BAT and stimulated by norepinephrine [14]. Various drugs including opiates and benzodiazepines are known to block these receptors, thereby reducing BAT FDG uptake [24]. Barrington and Maisey [22] demonstrated that oral diazepam given before the uptake period can reduce or suppress neck and paravertebral BAT FDG uptake in adults. Furthermore, Parysow et al. [33] showed that a low dose of 20 mg of oral propranolol given 60 min prior to 18F-FDG administration can reduce BAT FDG uptake in adults. In children, Gelfand et al. [24] showed that intravenous fentanyl (0.75–1.0 μg/kg up to a maximum dose of 50 μg given 10 min prior to 18F-FDG injection with appropriate monitoring) can significantly reduce BAT FDG uptake. However, Gelfand et al. [24] reported that low-dose diazepam did not reduce BAT FDG uptake. Similarly, in a randomized control trial, Sturkenboom et al. [34] reported that low-dose diazepam did not significantly suppress BAT FDG uptake in adults.
Diet
Recently, Williams and Kolodny [35] reported significantly decreased BAT FDG uptake and blood glucose levels when using a high-fat diet protocol. Patients were instructed to eat a high-fat and low-carbohydrate diet the night before and the morning of the 18F-FDG PET study [35]. The effect of this high-fat diet on BAT uptake is likely related to fatty-acid loading, which elicits thermogenesis without significant glucose metabolism [35]. However, the effect of the high-fat diet on tumor FDG uptake has not been fully explored [35].
Warming
As discussed earlier, warming children prior to and after the injection of 18F-FDG is a safe non-pharmacological approach to prevent BAT FDG uptake [31]. Note that patient warming should begin at least 30 min prior to FDG injection; warming after the FDG injection will not suppress BAT FDG uptake. However, in addition to adjusting room temperature, wrapping patients in heated or non-heated blankets during scanning, and asking patients to dress warmly and avoid cold environments on the day of the 18F-FDG PET might further minimize the incidence of metabolically active BAT FDG uptake.
Conclusion
Compared to adults, metabolically active BAT is more common in pediatric imaging. While the anatomical distribution of BAT is relatively widespread during the first decade of life, BAT becomes concentrated in certain anatomical regions with increasing age. Although 18F-FDG uptake in metabolically active BAT is typically bilateral and symmetrical, uptake that is focal and asymmetrical is not uncommon in certain locations. Careful attention to anatomical location on CT is needed to avoid misinterpretation, potentially leading to false-positive results on oncological studies. The use of combined 18F-FDG PET/CT can improve diagnostic accuracy by helping to rule out abnormality.
Although adult studies suggest that BAT FDG uptake is influenced by physical traits such as age, gender and BMI, these relationships are less clear in children and further research in the pediatric population is needed. However, based on pediatric studies that have been published, in order to minimize BAT FDG uptake, exposure to cold temperatures should be limited prior to 18F-FDG PET, and patients should be warmed before and during the uptake phase prior to imaging. At the Society for Pediatric Radiology Annual Meeting, which took place in Boston, MA, in April 2010, an informal survey was conducted by Dr. S.T. Treves to assess the methods currently employed in reducing BAT FDG uptake (personal communication). The survey included nine pediatric institutions in North America and suggested that the most commonly used methods for preventing brown fat FDG uptake were room temperature control (8 of 9) and warm blankets (7 of 9). Medications were used at 3 of 9 institutions. Overall, the use of the techniques reviewed in this article might significantly reduce BAT FDG uptake, enabling more efficient and accurate image interpretation.
References
Depas G, De Barsy C, Jerusalem G et al (2005) 18F-FDG PET in children with lymphomas. Eur J Nucl Med Mol Imaging 32:31–38
Franzius C, Schober O (2003) Assessment of therapy response by FDG PET in pediatric patients. Q J Nucl Med 47:41–45
Hudson MM, Krasin MJ, Kaste SC (2004) PET imaging in pediatric Hodgkin’s lymphoma. Pediatr Radiol 34:190–198
Shulkin BL, Mitchell DS, Ungar DR et al (1995) Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies. Radiology 194:495–500
Tatsumi M, Miller JH, Wahl RL (2007) 18F-FDG PET/CT in evaluating non-CNS pediatric malignancies. J Nucl Med 48:1923–1931
Abouzied MM, Crawford ES, Nabi HA (2005) 18F-FDG imaging: pitfalls and artifacts. J Nucl Med Technol 33:145–155, quiz 162–163
O’Hara SM, Donnelly LF, Coleman RE (1999) Pediatric body applications of FDG PET. AJR 172:1019–1024
Blodgett TM, Meltzer CC, Townsend DW (2007) PET/CT: form and function. Radiology 242:360–385
Cohade C, Osman M, Pannu HK et al (2003) Uptake in supraclavicular area fat (‘USA-fat’): description on 18F-FDG PET/CT. J Nucl Med 44:170–176
Truong MT, Erasmus JJ, Munden RF et al (2004) Focal FDG uptake in mediastinal brown fat mimicking malignancy: a potential pitfall resolved on PET/CT. AJR 183:1127–1132
Yeung HW, Grewal RK, Gonen M et al (2003) Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET. J Nucl Med 44:1789–1796
Heaton JM (1972) The distribution of brown adipose tissue in the human. J Anat 112:35–39
Cohade C (2010) Altered biodistribution on FDG-PET with emphasis on brown fat and insulin effect. Semin Nucl Med 40:283–293
Cannon B, Nedergaard J (2004) Brown adipose tissue: function and physiological significance. Physiol Rev 84:277–359
Nedergaard J, Bengtsson T, Cannon B (2007) Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 293:E444–452
Del Mar Gonzalez-Barroso M, Ricquier D, Cassard-Doulcier AM (2000) The human uncoupling protein-1 gene (UCP1): present status and perspectives in obesity research. Obes Rev 1:61–72
Nicholls DG, Rial E (1999) A history of the first uncoupling protein, UCP1. J Bioenerg Biomembr 31:399–406
Kawashita NH, Brito MN, Brito SR et al (2002) Glucose uptake, glucose transporter GLUT4, and glycolytic enzymes in brown adipose tissue from rats adapted to a high-protein diet. Metabolism 51:1501–1505
Olichon-Berthe C, Van Obberghen E, Le Marchand-Brustel Y (1992) Effect of cold acclimation on the expression of glucose transporter GLUT 4. Mol Cell Endocrinol 89:11–18
Lardinois D, Weder W, Hany TF et al (2003) Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 348:2500–2507
Okuyama C, Sakane N, Yoshida T et al (2002) (123)I- or (125)I-metaiodobenzylguanidine visualization of brown adipose tissue. J Nucl Med 43:1234–1240
Barrington SF, Maisey MN (1996) Skeletal muscle uptake of fluorine-18-FDG: effect of oral diazepam. J Nucl Med 37:1127–1129
Hany TF, Gharehpapagh E, Kamel EM et al (2002) Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region. Eur J Nucl Med Mol Imaging 29:1393–1398
Gelfand MJ, O'Hara SM, Curtwright LA et al (2005) Pre-medication to block [(18)F]FDG uptake in the brown adipose tissue of pediatric and adolescent patients. Pediatr Radiol 35:984–990
Cypess AM, Lehman S, Williams G et al (2009) Identification and importance of brown adipose tissue in adult humans. N Engl J Med 360:1509–1517
Rodriguez-Cuenca S, Pujol E, Justo R et al (2002) Sex-dependent thermogenesis, differences in mitochondrial morphology and function, and adrenergic response in brown adipose tissue. J Biol Chem 277:42958–42963
Tennefors C, Forsum E (2004) Assessment of body fatness in young children using the skinfold technique and BMI vs. body water dilution. Eur J Clin Nutr 58:541–547
Cohade C, Mourtzikos KA, Wahl RL (2003) ‘USA-fat’: prevalence is related to ambient outdoor temperature-evaluation with 18F-FDG PET/CT. J Nucl Med 44:1267–1270
Kim S, Krynyckyi BR, Machac J et al (2008) Temporal relation between temperature change and FDG uptake in brown adipose tissue. Eur J Nucl Med Mol Imaging 35:984–989
Zukotynski KA, Fahey FH, Laffin S et al (2010) Seasonal variation in the effect of constant ambient temperature of 24°C in reducing FDG uptake by brown adipose tissue in children. Eur J Nucl Med Mol Imaging 37:1854–1860
Christensen CR, Clark PB, Morton KA (2006) Reversal of hypermetabolic brown adipose tissue in F-18 FDG PET imaging. Clin Nucl Med 31:193–196
Bar-Sever Z, Keidar Z, Ben-Barak A et al (2007) The incremental value of 18F-FDG PET/CT in paediatric malignancies. Eur J Nucl Med Mol Imaging 34:630–637
Parysow O, Mollerach AM, Jager V et al (2007) Low-dose oral propranolol could reduce brown adipose tissue F-18 FDG uptake in patients undergoing PET scans. Clin Nucl Med 32:351–357
Sturkenboom MG, Hoekstra OS, Postema EJ et al (2009) A randomised controlled trial assessing the effect of oral diazepam on 18F-FDG uptake in the neck and upper chest region. Mol Imaging Biol 11:364–368
Williams G, Kolodny GM (2008) Method for decreasing uptake of 18F-FDG by hypermetabolic brown adipose tissue on PET. AJR 190:1406–1409
Acknowledgements
We would like to thank Dr. S.T. Treves for allowing us to include his data in this review. In addition, we would like to thank Wendy Doda, Tommy Stuleanu and Pallavi Sriram for their help in the preparation of our manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hong, T.S., Shammas, A., Charron, M. et al. Brown adipose tissue 18F-FDG uptake in pediatric PET/CT imaging. Pediatr Radiol 41, 759–768 (2011). https://doi.org/10.1007/s00247-010-1925-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-010-1925-y